Analysis of the expression of molecules that are known to be expressed by TAMs revealed that, in contrast to GLPM outside the tumor environment, GLPMs that were localized within the tumors upregulated checkpoint molecule PD-L1, but not PD-1, MHC-II or CD80 (Fig. 5c, d). The gene discussed is CD80; the disease is neoplasm.